22, 2024 — A large-scale clinical trial of treatment strategies for Crohn's disease ... and children ... Developing a Less Invasive Test for Inflammatory Bowel Disease Sep.

Early treatment of pediatric Crohn's disease with anti-tumor necrosis factor medications can substantially reduce the risk of ...

Remestemcel-L is under clinical development by Mesoblast and currently in Phase III for Crohn's Disease (Regional Enteritis).

For pediatric patients with Crohn disease, early anti-tumor necrosis factor-alpha (anti-TNFα) therapy is beneficial in ...

Steqeyma is approved for adult and pediatric patients with plaque psoriasis and active psoriatic arthritis as well as adults ...

Infliximab biosimilar is under clinical development by Celltrion and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

A new quick-and-easy nasal swab test for kids can diagnose the specific immune system drivers behind their asthma, ...

AbbVie's IL-23 inhibitor Skyrizi trailed some of its rivals in its first indication psoriasis, but has leapfrogged into first place in Crohn's disease ... be used to treat adults with moderate ...

Crohn's disease and ulcerative colitis are ... subsets of patients for whom the natural history of disease and response to treatment are predictable. The most widely held hypothesis on the ...

Intestinal ultrasound (IU) can be considered a screening tool for pediatric inflammatory bowel disease (IBD), according ...

A recent study conducted on medical students by Peruvian researchers found that there may be a link between a chronic ...

Fact checked by Nick Blackmer An ostomy surgery can be a life-changing procedure for people with Crohn’s disease, helping ...